arrow_back Back to App

Stop Pills That Kill Act: Combating Counterfeit Fentanyl and Methamphetamine

This act aims to enhance public safety by increasing penalties for trafficking counterfeit substances containing fentanyl or methamphetamine. It introduces new enforcement and education measures to protect individuals from dangerous substances disguised as prescription or over-the-counter medications. Citizens can expect greater protection from counterfeit drugs and increased awareness of the risks.
Key points
Stricter penalties for selling counterfeit pills containing fentanyl or methamphetamine disguised as medication.
Strengthening law enforcement efforts to combat illegal trafficking of these substances.
Increasing education and public awareness campaigns, especially for youth, about the dangers of counterfeit drugs.
Requiring regular reports to Congress on data regarding seizures and prosecutions of counterfeit substances.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_8175
Sponsor: Rep. Buck, Ken [R-CO-4]
Process start date: 2022-06-22
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Stop Pills That Kill Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8175.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-06-22.

What are the main provisions?

Key points include:

  • Stricter penalties for selling counterfeit pills containing fentanyl or methamphetamine disguised as medication.
  • Strengthening law enforcement efforts to combat illegal trafficking of these substances.
  • Increasing education and public awareness campaigns, especially for youth, about the dangers of counterfeit drugs.
  • Requiring regular reports to Congress on data regarding seizures and prosecutions of counterfeit substances.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Buck, Ken [R-CO-4].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Security Courts and Law Health